Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Ductal Adenocarcinoma

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

185 public trials 75 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations: Cedars-Sinai Medical Center West Hollywood, California, United States

University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View all 27 locations

View Trial Details

Completed

DC Vaccine in Pancreatic Cancer

NCT03592888

Conditions: Pancreatic Ductal Adenocarcinoma
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma

NCT05440942

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Completed

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer

NCT05303090

Conditions: Pancreatic Ductal Adenocarcinoma
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Completed

Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)

NCT05727319

Conditions: Pancreatic Ductal Adenocarcinoma
Locations: Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

View Trial Details

Completed

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

NCT04662112

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Hallym University Medical Center Anyang-si, Gyeonggi-do, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Completed

A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

NCT05031494

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Ichan School of Medicine at Mount Sinai New York, United States

Epworth Medical Centre Richmond, Victoria, Australia

View Trial Details

Completed

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

NCT04740164

Conditions: Bile Duct Carcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC

NCT04726956

Conditions: Pancreatic Ductal Adenocarcinoma
Locations: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

Changhai Hospital of Shanghai Shanghai, China

The First Affiliated Hospital of Zhengzhou University Zhengzhou, China

View Trial Details

Completed

Olaparib in Treating Patients With Stage IV Pancreatic Cancer

NCT02677038

Conditions: Metastatic Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details